Home
This site is intended for healthcare professionals
MedAll Neurology
MedAll Neurology
faizan Khan
Sarah Islam
Team MedAll
Abdulrazzaq Al-Shajani
SHAH FAHAD
Alireza Pourrahim
NEERAJKANTH PILLA
Dr. Himanshu
MOHAMAD YOUSEF MOHAMAD HEEH
Moyinoluwa Daniels
Nabila Tahseen
Gemma Thomas
Hamidullah Habib
Arif Uddin
Prof. Hassan Alshatoury
Julia Dowdle
Susan Garcia Rincal
faizan Khan
Sarah Islam
Team MedAll
Abdulrazzaq Al-Shajani
SHAH FAHAD
Alireza Pourrahim
NEERAJKANTH PILLA
Dr. Himanshu
MOHAMAD YOUSEF MOHAMAD HEEH
Moyinoluwa Daniels
Nabila Tahseen
Gemma Thomas
16 members, 328 followers

The discussion starts here!

Community threads is a place for you to come together, support each other and discuss the topics important to you.

MedAll Editor
MedAll Editor
Posted by MedAll Editor  |  27 Nov 2024 (Edited)
27 Nov 2024 (Edited)

Secondary Stroke Prevention Forum Case: Anticoagulants

Can you answer the questions about this case ahead of joining the live teaching session?

A 65-year-old male presents to your clinic following a recent ischemic stroke. He has a history of hypertension, hyperlipidemia, and type 2 diabetes. His imaging reveals a large artery atherosclerosis in his left internal carotid artery. He was previously intolerant of aspirin due to significant gastrointestinal upset.

  1. What are the current standard antithrombotic options for this patient?
  2. What specific factors would you consider when assessing the suitability for an anticoagulant?
  3. What pros and cons exist of the current anticoagulant therapies?

This program is funded by an independent grant from Bayer. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Show more

Secondary Stroke Prevention Forum Case: Anticoagulants

Can you answer the questions about this case ahead of joining the live teaching session?

A 65-year-old male presents to your clinic following a recent ischemic stroke. He has a history of hypertension, hyperlipidemia, and type 2 diabetes. His imaging reveals a large artery atherosclerosis in his left internal carotid artery. He was previously intolerant of aspirin due to significant gastrointestinal upset.

  1. What are the current standard antithrombotic options for this patient?
  2. What specific factors would you consider when assessing the suitability for an anticoagulant?
  3. What pros and cons exist of the current anticoagulant therapies?

This program is funded by an independent grant from Bayer. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Show more

MedAll Editor
MedAll Editor
Posted by MedAll Editor  |  7 Nov 2024 (Edited)
7 Nov 2024 (Edited)

Secondary Stroke Prevention Forum Case: Management

Can you answer the questions about this case ahead of joining the live teaching session?

A 54-year-old male with a history of transient ischemic attack (TIA) presented with two episodes of acute ischemic stroke. The first episode, in 2006, was successfully treated with intravenous tissue plasminogen activator (IV TPA), intra-arterial TPA, and mechanical thrombectomy. The second episode occurred after a brief interruption of aspirin therapy and was managed conservatively due to delayed presentation. Despite dual antiplatelet therapy (DAPT), the patient developed a persistent M1 occlusion with subsequent thrombus formation. Subsequent investigations, including transcranial Doppler (TCD) and cerebral angiography, failed to identify a clear embolic source. The patient underwent carotid endarterectomy (CEA), which revealed focal shelf-like projections of fibrotic intima without atherosclerotic changes. Since the procedure, the patient has remained stroke-free.

This program is funded by an independent grant from Bayer. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Secondary Stroke Prevention Forum Case: Management

Can you answer the questions about this case ahead of joining the live teaching session?

A 54-year-old male with a history of transient ischemic attack (TIA) presented with two episodes of acute ischemic stroke. The first episode, in 2006, was successfully treated with intravenous tissue plasminogen activator (IV TPA), intra-arterial TPA, and mechanical thrombectomy. The second episode occurred after a brief interruption of aspirin therapy and was managed conservatively due to delayed presentation. Despite dual antiplatelet therapy (DAPT), the patient developed a persistent M1 occlusion with subsequent thrombus formation. Subsequent investigations, including transcranial Doppler (TCD) and cerebral angiography, failed to identify a clear embolic source. The patient underwent carotid endarterectomy (CEA), which revealed focal shelf-like projections of fibrotic intima without atherosclerotic changes. Since the procedure, the patient has remained stroke-free.

This program is funded by an independent grant from Bayer. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.